Erythropoietin levels in lowlanders and high-altitude natives at 3450 m

Aviation Space and Environmental Medicine

Volumn 78, Issue 10, 2007, Pages 963-967

  Basu, Minakshi ^a   Malhotra, Anand Swroop ^a   Pal, Karan ^a   Prasad, Rajendra ^a   Kumar, Rajesh ^a   Prasad, B A K ^b   Sawhney, Ramesh Chand ^a  

^a DEFENCE INSTITUTE OF PHYSIOLOGY AND ALLIED SCIENCES   (India)

^b High Altitude Med Res Center   (India)

Author keywords

Acute mountain sickness; Erythropoietin; High altitude; High altitude natives; High altitude pulmonary edema

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN;

ADULT; ALTITUDE; ALTITUDE ACCLIMATIZATION; ALTITUDE DISEASE; ARTICLE; DEMOGRAPHY; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN EXPERIMENT; HYPOXEMIA; LUNG EDEMA; MALE; NORMAL HUMAN; PROTEIN BLOOD LEVEL;

ACCLIMATIZATION; ADULT; ALTITUDE; ANALYSIS OF VARIANCE; ANOXIA; ERYTHROPOIETIN; HEMATOCRIT; HUMANS; MALE; TIME FACTORS;

EID: 34848879824     PISSN: 00956562     EISSN: None     Source Type: Journal    
DOI: 10.3357/ASEM.2085.2007     Document Type: Article

References (29)

1. Aaronson PI, Robertson TP, Ward JP. Endothelin-derived mediators and hypoxic pulmonary vasoconstriction. Respir Physiol Neurobiol 2002; 132:107-20.
2. Bartsch P, Roach R. Acute mountain sickness and high-altitude cerebral edema. In: Hormbein TF, ed. High altitude. New York: Marcel Dekker, Inc.; 2001: 743-4.
3. Bartsch P, Shaw S, Franciolli M, Gnadinger MP, Weidmann P. Atrial natriuretic peptide in acute mountain sickness. J Appl Physiol 1988; 65:1929-37.
4. Basu M, Sawhney RC, Kumar S, Pal K, Prasad R, Selvamurthy W. Hypothalamic-pituitary-adrenal axis following glucocorticoid prophylaxis against acute mountain sickness. Horm Metab Res 2002; 34:318-24.
5. Bauer C, Kurtz A. Oxygen sensing in the kidney and its relation to erythropoietin production. Annu Rev Physiol 1989; 51:845-56.
6. Brier ME, Bunke CM, Lathon PV, Aronoff GR. Erythropoietin-induced antinatriuresis mediated by angiotensin II in perfused kidneys. J Am Soc Nephrol 1993; 3:1583-90.
7. Carlini RG, Dusso AS, Obialo CI, Alvarez UM, Rothstein M. Recombinant human erythropoietin (rHuEPO) increases endothelin-1 release by endothelial cells. Kidney Int 1993; 43:1010-4.
8. th ed. New York: Churchill Livingstone; 1986: 28-33.
9. Eckardt KU, Boutellier U, Kurtz A, Schopen M, Koller EA, Bauer C. Rate of erythropoietin formulation in humans in response to acute hypobaric hypoxia. J Appl Physiol 1989; 66:1785-8.
10. Eschbach JW, Abdulhadi MH, Browne JK, Delano BG, Downing MR, Egrie JC, et al. Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of phase III multicenter clinical trial. Arm Intern Med 1989; 111:992-1000.
11. Fandrey J, Pagel H, Frede S, Wolff M, Jelkmann W. Thyroid hormones enhance hypoxia induced erythropoietin production in-vitro. Exp Hematol 1994; 22:272-7.
12. Faulds D, Sorkin EM. Epoetin (recombinant human erythropoietin). A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in anaemia and the stimulation of erythropoiesis. Drugs 1989; 38:863-99.
13. Gunga HC, Rochker L, Behan C, Hildebrandt W, Koralewski E, Rich I, et al. Shift working in the Chilean Andes (> 3,600 m) and its influence on erythropoietin and the low-pressure system. J Appl Physiol 1996; 81:846-52.
14. Hofer T, Wenger H, Grassmann M. Oxygen sensing, HIF-1α stabilization and potential therapeutic strategies. Pflugers Arch 2002; 443:503-7.
15. Hudson JG, Bowen AL, Navia P, Rios-Dalenz J, Pollard AJ, Williams D, et al. The effect of high altitude on platelet counts, thrombopoietin and erythropoietin levels in young Bolivian airmen visiting the Andes. Int J Biometeorol 1999; 43:85-90.
16. Kohan DE. Endothelines in the normal and diseased kidney. Am J Kidney Dis 1997; 29:2-26.
17. Koistinen PO, Rusko H, Irjala K, Rajamaki A, Penttinen K, Sarparanta VP, et al. EPO, red cells, and serum transferring receptor in continuous and intermittent hypoxia. Med Sci Sports Exerc 2000; 32:800-4.
18. Krantz SB. Erythropoietin. Blood 1991; 77:419-34.
19. Ma Y, Freitag P, Zhou J, Brune B, Frede S, Fandrey J. Thyroid hormone induces erythropoietin gene expression through augmented accumulation of hypoxia induced factor-1. Am J Physiol Regul Integr Comp Physiol 2004; 287:R600-7.
20. Mazzeo RS, Wolfel EE, Butterfield GE, Reeves JT. Sympathetic responses during 21 days at high altitude (4300m) as determined by urinary and arterial catecholamines. Metabolism 1994; 43:1226-32.
21. Milledge JS, Cotes PM. Serum erythropoietin in humans at high-altitude and its relation to plasma renin. J Appl Physiol 1985; 59:360-4.
22. Mordes JP, Blume FD, Boyer S, Zheng MR, Braveman LE. High altitude pituitary thyroid dysfunction on Mount Everest. N Engl J Med 1983; 308:1135-8.
23. Pavlicek V, Marti HH, Grad S, Gibbs JS, Kol C, Wenger RH, et al. Effects of hypobaric hypoxia on vascular endothelial growth factor and the acute phase response in subjects who are susceptible to high-altitude pulmonary edema. Eur J Appl Physiol 2000; 81:497-503.
24. Rastogi GK, Malhotra MS, Srivastava MC, Sawhney RC, Dua GL, Sridharan K, et al. Study of the pituitary-thyroid function at high altitude in man. J Clin Endocrinol Metab 1977; 44:447-52.
25. Rodriguez FA, Ventura JL, Casas M, Cases H, Pages T, Rama R, et al. Erythropoietin acute reaction and hematological adaptations to short, intermittent hypobaric hypoxia. Eur J Appl Physiol 2000; 82:170-7.
26. Savourey G, Garcia N, Besnard Y, Guinet A, Hanniquet AM, Bittel J. Pre-adaptation, adaptation and de-adaptation to high altitude in humans: cardio ventilatory and hematological changes. Eur J Appl Physiol Occup Physiol 1996; 73:529-35.
27. Sawhney RC, Malhotra AS, Singh T. Glucoregulatory hormones in man at high altitude. Eur J Appl Physiol Occup Physiol 1991; 62:286-91.
28. Schoene RB, Swenson ER, Hultgren HN. High altitude pulmonary edema. In: Hormbein TF, ed. High altitude. New York: Marcel Dekker, Inc.; 2001:783-784.
29. West JB. Acclimatization to high altitude: truths and misconceptions. High Alt Med Biol 2003; 4:401-2.